Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study.

Luigi GargiuloGiulia PaviaMario ValentiAna Lleo de NaldaChiara PeruginiAntonio CostanzoAlessandra Narcisi

Published in: Dermatology and therapy (2022)

Biologic therapies (including anti-IL-23 drugs) appear to be safe in patients seropositive for HCV or HBV core antibody who did not receive antiviral prophylaxis.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
sars cov
peritoneal dialysis
early onset
patient reported outcomes
drug induced
liver failure
hiv infected